These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 26923204)
1. Plasma cells as an innovative target in autoimmune disease with renal manifestations. Hiepe F; Radbruch A Nat Rev Nephrol; 2016 Apr; 12(4):232-40. PubMed ID: 26923204 [TBL] [Abstract][Full Text] [Related]
2. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis. Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925 [TBL] [Abstract][Full Text] [Related]
3. Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity. Mumtaz IM; Hoyer BF; Panne D; Moser K; Winter O; Cheng QY; Yoshida T; Burmester GR; Radbruch A; Manz RA; Hiepe F J Autoimmun; 2012 Sep; 39(3):180-8. PubMed ID: 22727274 [TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors. Alexander T; Cheng Q; Klotsche J; Khodadadi L; Waka A; Biesen R; Hoyer BF; Burmester GR; Radbruch A; Hiepe F Eur J Immunol; 2018 Sep; 48(9):1573-1579. PubMed ID: 29979809 [TBL] [Abstract][Full Text] [Related]
5. Long-lived plasma cells and their contribution to autoimmunity. Hoyer BF; Manz RA; Radbruch A; Hiepe F Ann N Y Acad Sci; 2005 Jun; 1050():124-33. PubMed ID: 16014527 [TBL] [Abstract][Full Text] [Related]
6. [Autoantibodies and antibody-secreting cells]. Hiepe F; Dörner T Z Rheumatol; 2005 Sep; 64(6):389-95. PubMed ID: 16184346 [TBL] [Abstract][Full Text] [Related]
7. Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice. Khodadadi L; Cheng Q; Alexander T; Sercan-Alp Ö; Klotsche J; Radbruch A; Hiepe F; Hoyer BF; Taddeo A PLoS One; 2015; 10(8):e0135081. PubMed ID: 26252021 [TBL] [Abstract][Full Text] [Related]
8. How to cope with pathogenic long-lived plasma cells in autoimmune diseases. Hoyer BF; Mumtaz IM; Yoshida T; Hiepe F; Radbruch A Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii87-9. PubMed ID: 19022822 [TBL] [Abstract][Full Text] [Related]
9. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice. Starke C; Frey S; Wellmann U; Urbonaviciute V; Herrmann M; Amann K; Schett G; Winkler T; Voll RE Eur J Immunol; 2011 Jul; 41(7):2107-12. PubMed ID: 21484784 [TBL] [Abstract][Full Text] [Related]
10. [Plasma cells]. Hiepe F; Alexander T; Voll RE Z Rheumatol; 2015 Feb; 74(1):20-5. PubMed ID: 25616773 [TBL] [Abstract][Full Text] [Related]
13. Allergy for a lifetime? Luger EO; Wegmann M; Achatz G; Worm M; Renz H; Radbruch A Allergol Int; 2010 Mar; 59(1):1-8. PubMed ID: 20186004 [TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells. Ichikawa HT; Conley T; Muchamuel T; Jiang J; Lee S; Owen T; Barnard J; Nevarez S; Goldman BI; Kirk CJ; Looney RJ; Anolik JH Arthritis Rheum; 2012 Feb; 64(2):493-503. PubMed ID: 21905015 [TBL] [Abstract][Full Text] [Related]
15. Pathogenic long-lived plasma cells and their survival niches in autoimmunity, malignancy, and allergy. Winter O; Dame C; Jundt F; Hiepe F J Immunol; 2012 Dec; 189(11):5105-11. PubMed ID: 23169863 [TBL] [Abstract][Full Text] [Related]
16. The long and the short of it: insights into the cellular source of autoantibodies as revealed by B cell depletion therapy. Hale M; Rawlings DJ; Jackson SW Curr Opin Immunol; 2018 Dec; 55():81-88. PubMed ID: 30390507 [TBL] [Abstract][Full Text] [Related]